Abiopharma

SINTX Technologies signe un accord dʼapprovisionnement avec EVONIK pour la production dʼun composé de nitrure de silicium et de PEEK destiné à la fabrication dʼimplants sur mesure imprimés en 3D et assistés par lʼIA

シンテックス・テクノロジーズ、AI支援型3Dプリント患者特異的インプラント向け窒化ケイ素-PEEK複合材を製造する供給契約をエボニックと締結

SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate

SINTX Technologies Menandatangani Perjanjian Bekalan dengan EVONIK untuk Menghasilkan Sebatian Silikon Nitrida–PEEK untuk Implan Khusus Pesakit Berbantukan AI, Cetakan 3D

SINTX Technologies, AI 적용한 3D 프린팅 환자 맞춤형 임플란트 위한 실리콘 나이트라이드–PEEK 복합소재 제조 위해 EVONIK과 계약 체결

SINTX Technologies Contrata EVONIK para Fornecimento de Composto de Nitreto de Silício-PEEK para Implantes Específicos para Pacientes Assistidos por IA e Impressos em 3D

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

Citius Oncology - Citius Oncology Announces U.S. Commercial Launch ofLYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

Longeveron - Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with MildAlzheimer’s Disease Presented at the Clinical Trials onAlzheimer’s Disease Conference (CTAD 2025)